QID 174982

Date Published: 2021-05-06

QID 174982: SUSE Enterprise Linux Security Update for samba (SUSE-SU-2021:1498-1)

This update for samba fixes the following issues:

- CVE-2021-20277: Fixed an out of bounds read in ldb_handler_fold
(bsc#1183574).
- CVE-2021-20254: Fixed a buffer overrun in sids_to_unixids()
(bsc#1184677).
- CVE-2020-27840: Fixed an unauthenticated remote heap corruption via bad
DNs (bsc#1183572).
- Avoid free'ing our own pointer in memcache when memcache_trim attempts
to reduce cache size (bsc#1179156).
- s3-libads: use dns name to open a ldap session (bsc#1184310).
- Adjust smbcacls '--propagate-inheritance' feature to align with upstream
(bsc#1178469).

Successful exploitation allows attacker to compromise the system.

CVSS V3 rated as Critical - 8.1 severity.

CVSS V2 rated as Medium - 5.5 severity.

Solution

Upgrade to the latest package which contains the patch. To install this SUSE Security, Update use YaST online_update. Alternatively you can run the command listed for your product. To install packages using the command line interface, use command "yum update". Refer to Suse security advisory: SUSE-SU-2021:1498-1 to address this issue and obtain further details.

Vendor References

SUSE-SU-2021:1498-1 - lists.suse.com/pipermail/sle-security-updates/2021-May/008730.html

CVEs related to QID 174982

CVE-2021-20254 | CVE-2021-20277 | CVE-2020-27840 |

Software Advisories

Advisory ID	Software	Component	Link
SUSE-SU-2021:1498-1	SUSE Enterprise Linux		lists.suse.com/pipermail/sle-security-updates/2021-May/008730.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].